Epigenetic re-expression of HIF-2α suppresses soft tissue sarcoma growth
Hypoxia is a common feature of soft tissue sarcomas, resulting in the activation of HIF-1α, which promotes metastasis. Here, Nakazawa et al. show that paradoxically HIF-2α is epigenetically silenced during the progression of multiple sarcoma subtypes, and when reexpressed, blocks tumour growth in vi...
Main Authors: | Michael S. Nakazawa, T. S. Karin Eisinger-Mathason, Navid Sadri, Joshua D. Ochocki, Terence P. F. Gade, Ruchi K. Amin, M. Celeste Simon |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2016-02-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/ncomms10539 |
Similar Items
-
Hypoxia-Inducible Factors: Mediators of Cancer Progression; Prognostic and Therapeutic Targets in Soft Tissue Sarcomas
by: Paul J. Zhang, et al.
Published: (2013-04-01) -
Prospects for Epigenetic Targeted Therapies of Bone and Soft-Tissue Sarcomas
by: Jun Wang, et al.
Published: (2021-01-01) -
Epigenetic reprogramming and re-differentiation of a Ewing sarcoma cell line
by: Joseph Brady Moore IV, et al.
Published: (2015-03-01) -
Targeting glutamine metabolism slows soft tissue sarcoma growth
by: Pearl Lee, et al.
Published: (2020-01-01) -
Inflammation, HIF-1, and the Epigenetics That Follows
by: Claudio Brigati, et al.
Published: (2010-01-01)